Products with Cytotoxic bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN6491 | 3,5-Di-O-caffeoylquinic acid methyl ester |
| 3,5-Di-O-caffeoylquinic acid methyl ester exhibits potent inhibitory activities against the formation of advanced glycation end products (AGEs); it exhibits cytotoxicity actions against human cervix carcinoma HeLa cells. 3,5-Di-O-caffeoylquinic acid methyl ester shows high efficiency and low toxicity with antivirus activity against RSV. | |
| BCN6499 | 3,4-Dimethoxycinnamyl alcohol |
| 1. 3,4-Dimethoxycinnamyl alcohol shows significant antimicrobial and cytotoxic activities. | |
| BCN6524 | Cepharadione B |
| 1. Cepharadione B exhibits strong tyrosinase inhibitory activity with an IC50 value of 170 microM. 2. Cepharadione B exhibits significant cytotoxicity against five human tumor cell lines (A-549, SK-OV-3, SK-MEL-2, XF-498 and HCT-15) in vitro. | |
| BCN6526 | Continentalic acid |
| 1. Continentalic acid and kaurenoic acid are quality control markers in Aralia continentalis. 2. Continentalic acid shows moderate cytotoxicity against A-549 (lung), THP-1 (leukemia) and MCF-7 (breast) cell lines. 3. Continentalic acid exerts significant anti-inflammatory activity. 4. Continentalic acid can efficiently induces apoptosis and is a good candidate for further evaluation as an effective chemotherapeutic agent. 5. Continentalic acid has minimum inhibitory concentrations (MICs) of approximately 8-16 microg/mL against S. aureus, including the MSSA and MRSA standard strains. | |
| BCN6553 | Hederacolchiside A1 |
| 1. Hederacolchiside A1 shows antiproliferation activities in three cancer cell lines with the IC50 value of 2.4 uM. 2. Hederacolchiside A1 has antimelanoma potential. 3. Hederacolchiside A1 exhibits a preferential cytotoxicity on a pigmented melanoma cell line. 4. Hederacolchiside A1 shows anti-leishmanial activity, it exhibits a strong antiproliferative activity on all stages of development of the parasite by altering membrane integrity and potential. | |
